- Home
- IMG vs VINC Comparison
IMG vs VINC Comparison
Compare IMG & VINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMG
- VINC
- Stock Information
- Founded
- IMG 2011
- VINC 2019
- Country
- IMG United States
- VINC United States
- Employees
- IMG N/A
- VINC N/A
- Industry
- IMG
- VINC Biotechnology: Pharmaceutical Preparations
- Sector
- IMG
- VINC Health Care
- Exchange
- IMG NYSE
- VINC Nasdaq
- Market Cap
- IMG 7.1M
- VINC 6.2M
- IPO Year
- IMG 2020
- VINC N/A
- Fundamental
- Price
- IMG $0.68
- VINC $1.39
- Analyst Decision
- IMG
- VINC Buy
- Analyst Count
- IMG 0
- VINC 2
- Target Price
- IMG N/A
- VINC $2.00
- AVG Volume (30 Days)
- IMG 2.5M
- VINC 1.2M
- Earning Date
- IMG 02-11-2025
- VINC 03-28-2025
- Dividend Yield
- IMG N/A
- VINC N/A
- EPS Growth
- IMG N/A
- VINC N/A
- EPS
- IMG N/A
- VINC N/A
- Revenue
- IMG $3,785,663.00
- VINC N/A
- Revenue This Year
- IMG $99.05
- VINC N/A
- Revenue Next Year
- IMG $130.30
- VINC N/A
- P/E Ratio
- IMG N/A
- VINC N/A
- Revenue Growth
- IMG 109.62
- VINC N/A
- 52 Week Low
- IMG $0.25
- VINC $1.40
- 52 Week High
- IMG $8.00
- VINC $187.44
- Technical
- Relative Strength Index (RSI)
- IMG N/A
- VINC 28.94
- Support Level
- IMG N/A
- VINC $1.40
- Resistance Level
- IMG N/A
- VINC $1.66
- Average True Range (ATR)
- IMG 0.00
- VINC 0.32
- MACD
- IMG 0.00
- VINC -0.06
- Stochastic Oscillator
- IMG 0.00
- VINC 1.44
About IMG CIMG INC
CIMG Inc is a coffee and technologies company. The company is a co-packer of single-serve pour-over coffee, coffee brew bags and Dripkits. The company's brand portfolio includes Coffee Blenders, Twin Peaks, Active Cup, Relax Cup, Think Cup, Nude Cup, Pine Ranch Coffee, and Dripkit. Its geographical segments are North America, which accounts for the majority of revenue; and South Korea.
About VINC Vincerx Pharma Inc.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.